ARTICLE | Company News
GlaxoSmithKline, University of Dundee deal
June 13, 2011 7:00 AM UTC
GlaxoSmithKline partnered with the university to develop therapeutics to treat recessive dystrophic epidermolysis bullosa (RDEB), a condition where the skin and other body surfaces can develop deep bl...